Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 4
2004 3
2005 7
2006 3
2007 9
2008 9
2009 14
2010 6
2011 8
2012 12
2013 20
2014 12
2015 17
2016 15
2017 23
2018 26
2019 25
2020 27
2021 19
2022 25
2023 15
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

255 results

Results by year

Filters applied: . Clear all
Page 1
Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial.
Xu RH, Muro K, Morita S, Iwasa S, Han SW, Wang W, Kotaka M, Nakamura M, Ahn JB, Deng YH, Kato T, Cho SH, Ba Y, Matsuoka H, Lee KW, Zhang T, Yamada Y, Sakamoto J, Park YS, Kim TW. Xu RH, et al. Among authors: matsuoka h. Lancet Oncol. 2018 May;19(5):660-671. doi: 10.1016/S1470-2045(18)30140-2. Epub 2018 Mar 16. Lancet Oncol. 2018. PMID: 29555258 Clinical Trial.
Isolated Left Atrial Infective Mural Endocarditis.
Hosokawa S, Okayama H, Hiasa G, Kawamura G, Shigematsu T, Takahashi T, Kawada Y, Yamada T, Matsuoka H, Kazatani Y. Hosokawa S, et al. Among authors: matsuoka h. Intern Med. 2018 Apr 1;57(7):957-960. doi: 10.2169/internalmedicine.9559-17. Epub 2017 Dec 8. Intern Med. 2018. PMID: 29225261 Free PMC article. Review.
Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models.
Saito Y, Iida-Norita R, Afroj T, Refaat A, Hazama D, Komori S, Ohata S, Takai T, Oduori OS, Kotani T, Funakoshi Y, Koma YI, Murata Y, Yakushijin K, Matsuoka H, Minami H, Yokozaki H, Manz MG, Matozaki T. Saito Y, et al. Among authors: matsuoka h. Front Immunol. 2023 Dec 14;14:1294814. doi: 10.3389/fimmu.2023.1294814. eCollection 2023. Front Immunol. 2023. PMID: 38162643 Free PMC article.
Robotic Surgery for Rectal Cancer: Operative Technique and Review of the Literature.
Katsuno H, Hanai T, Masumori K, Koide Y, Ashida K, Matsuoka H, Tajima Y, Endo T, Mizuno M, Cheong Y, Maeda K, Uyama I. Katsuno H, et al. Among authors: matsuoka h. J Anus Rectum Colon. 2020 Jan 30;4(1):14-24. doi: 10.23922/jarc.2019-037. eCollection 2020. J Anus Rectum Colon. 2020. PMID: 32002472 Free PMC article. Review.
Regulation of fatty acid metabolism in bacteria.
Fujita Y, Matsuoka H, Hirooka K. Fujita Y, et al. Among authors: matsuoka h. Mol Microbiol. 2007 Nov;66(4):829-39. doi: 10.1111/j.1365-2958.2007.05947.x. Epub 2007 Oct 2. Mol Microbiol. 2007. PMID: 17919287 Free article. Review.
Asciminib vs bosutinib in CML patients pretreated with ≥2 tyrosine kinase inhibitors: Results from the Japanese subgroup analysis of ASCEMBL study.
Yuda J, Doki N, Matsuoka H, Yokota T, Tomita A, Takahashi N, Matsumura I, Kubo K, Goto T, Kirito K, Maki A, Aoki M, Allepuz A, Minami Y. Yuda J, et al. Among authors: matsuoka h. Cancer Med. 2023 Feb;12(3):2990-2998. doi: 10.1002/cam4.5212. Epub 2022 Sep 27. Cancer Med. 2023. PMID: 36168187 Free PMC article. Clinical Trial.
255 results